Objectives: Characterization of Proteus mirabilis isolates harbouring bla OXA-58 with emphasis on the genetic environment of this resistance determinant.
Introduction
Proteus mirabilis is a Gram-negative bacterium belonging to the Enterobacteriaceae family and occurs as an opportunistic pathogen mainly in complicated urinary tract infections. 1 The species is also frequently found in wound specimens. Rarely is P. mirabilis a cause of bacteremia. 2 Reports of multidrug resistance in P. mirabilis are rare and susceptibility rates for piperacillin/tazobactam, aztreonam, ceftazidime and meropenem exceed 90% in a recent report from Europe and the USA. 3 Reduced susceptibility to imipenem, however, is a well-known feature intrinsic to P. mirabilis and has been associated with reduced affinity of imipenem to PBP2. 4 Carbapenemases that have been described in P. mirabilis include KPC, VIM-1 and NDM-1 as well as OXA-48 and OXA-23. [5] [6] [7] [8] [9] The latter observation is of special interest since this is the only observation of the carbapenemase OXA-23 outside the genus Acinetobacter. Acquisition of a carbapenemase gene in the species P. mirabilis has serious clinical consequences because of intrinsic resistance to polymyxins and tigecycline, which can be used for treatment of infections caused by carbapenemase-producing bacteria in other Enterobacteriaceae species.
A carbapenemase not detected in P. mirabilis so far is OXA-58, a class D carbapenemase that was first described in an Acinetobacter baumannii strain isolated in 2003 in France, but later found in isolates dating back to 1995 and 1996. 10, 11 The hydrolysis spectrum of this b-lactamase comprises penicillins and carbapenems, but spares oxyimino cephalosporins and aztreonam. 10 The b-lactamase activity is inhibited by NaCl, but only weakly inhibited by clavulanic acid. 10 Since the first description of OXA-58 this enzyme has been almost exclusively described in the genus Acinetobacter, mainly in A. baumannii, but occasionally also in Acinetobacter pittii, Acinetobacter junii and Acinetobacter johnsonii.
11 Only one study claims to have found bla OXA-58 in various species such as Enterobacter cloacae, Escherichia coli or Klebsiella pneumoniae sometimes even together with bla OXA-51 like or bla DIM in isolates collected from a single hospital in Sierra Leone. 12 Prompted by a previous accidental observation of bla OXA-23 in a P. mirabilis isolate, a multiplex PCR for bla OXA-23 , bla OXA-40 and bla OXA-58 was included in the diagnostic workflow for carbapenemase detection for P. mirabilis isolates referred to our institution. Here, we describe P. mirabilis isolates producing the OXA-58 carbapenemase.
Materials and methods
The study was performed at Ruhr-University Bochum.
Strains
Laboratories from all over Germany were asked to refer P. mirabilis strains with reduced susceptibility for ertapenem or meropenem to our national reference laboratory for MDR Gram-negative bacteria. Between October 2013 and September 2015 37 strains of P. mirabilis isolated from different patients were investigated for the presence of a carbapenemase.
Detection of carbapenemases
For carbapenemase detection, a modified Hodge test with imipenem, meropenem and ertapenem was performed on MacConkey agar and CLED agar to inhibit swarming. Combined disc tests with EDTA and boronic acid and disc diffusion for temocillin were performed in addition to PCR and subsequent sequencing for bla KPC , bla OXA-48 like , bla VIM , bla IMP and bla NDM as previously described. 13 Furthermore, a multiplex PCR for bla OXA-23 , bla and bla OXA-58 was performed. 14 The Carba NP test was performed as described by Dortet et al.
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Detection of specific activity against imipenem in crude lysates
For lysate preparation, cells were grown in LB medium, harvested by centrifugation and lysed using glass beads after resuspension in 0.1 M PBS containing 50 mM sodium bicarbonate. The specific activity of the crude lysates against imipenem was determined spectrophotometrically at 297 nm in a volume of 210 lL at a final concentration of 19 lM imipenem at room temperature. The total protein content of the lysates was determined using a Qubit Fluorometer. All measurements were conducted with three different lysates for each strain.
Susceptibility testing
Susceptibility testing was performed according to EUCAST (http://www. eucast.org/clinical_breakpoints/) by microdilution using pre-configured microtitre plates (MERLIN Diagnostika GmbH, Bornheim-Hersel, Germany).
Molecular typing
The four isolates of P. mirabilis harbouring bla OXA-58 were typed by PFGE. Briefly, the strains were lysed in agarose plugs and the DNA was restricted with NotI. The fragments were then subjected to PFGE using the CHEF-DR-III system (Bio-Rad, Munich, Germany) with an initial switch time of 5 s, a final switch time of 50 s and 6 V/cm for 20 h at 14 C. The resulting band patterns were evaluated using criteria described previously. 16 
Conjugation experiments
For conjugation experiments, rifampicin-resistant E. coli C600 derivative and rifampicin-resistant A. baumannii BM4547 were used as recipient strains. The donor strains (either P. mirabilis 10797, 10818, 13153 and 17744) and the two recipient strains were cultivated on Columbia blood agar, and then grown for 5 h in Mueller-Hinton broth containing ampicillin (100 mg/L) or rifampicin (100 mg/L), respectively. The cultures were then mixed and plated on Columbia blood agar. Each of these conjugation attempts was performed twice; one plate was incubated overnight at 37 C while the other was incubated at 30 C. On the next day, the putative transconjugants were plated on Mueller-Hinton agar containing 50 mg/L ampicillin and 100 mg/L rifampicin and incubated at 37 C overnight. Transconjugants were verified by PCR for the bla OXA-58 gene and by MALDI-TOF for species confirmation.
Transformation experiments
Plasmid DNA from P. mirabilis 10797 and P. mirabilis 13153 was obtained using the NucleoBond Xtra Midi Kit (Macherey & Nagel). Transformation of p10797-OXA-58 into E. coli DH1 and A. baumannii ATCC 17978 was performed using an electroporation approach.
First, competent cells were generated by cultivating E. coli DH1 or A. baumannii ATCC 17978 and washing cell pellets three times in 10% glycerol. Different amounts of the isolated plasmid DNA ranging from 20 to 600 ng were added to individual aliquots of competent cells. The cells were electroporated in 0.2 cm electroporation cuvettes at 25 kV. After recovery in SOC broth for 1 h, transformants were streaked out on Mueller-Hinton agar containing 100 mg/L ampicillin.
Isolation of genomic DNA and sequencing
The strains were cultivated in LB broth at 37 C until an OD 600 of 0.7 was reached. High molecular genomic DNA was isolated using the Genomic Tips 100/G Kit (Qiagen) according to the manufacturer's instructions. A Qubit 2.0 Fluorometer was used to determine the DNA concentration and confirm the absence of protein and RNA contaminations. The integrity of high molecular DNA was assessed by agarose gel electrophoresis. The presence of bla OXA-58 in the isolated DNA was confirmed by PCR. WGS of the two strains was performed on an Illumina MiSeq platform by GATC Biotech (Konstanz, Germany) with 2 % 300 bp paired-end reads using libraries with an average insert size of 600 bp. Draft-genome assembly was performed in-house using the SPAdes-Assembler with k-mer sizes of 21, 33, 55, 77, 99 and 127. 17 The assemblies had an average coverage of at least 70-fold and contained fewer than 100 contigs. The resulting draft genomes were screened for the presence of bla OXA-58 using BLASTN (https://blast.ncbi.nlm. nih.gov/). Contigs with bla OXA-58 had identical sequences on their flanks and circularity was confirmed by PCR spanning from one flank of the contig to another. The primers used for this PCR were 5 0 -CCTGCTGATTGCAATAACGG-3 0 and 5 0 -GGCAAGGACACATATAGACG-3 0 . Plasmids from all strains harbouring bla OXA-58 were completely sequenced by Sanger sequencing.
Results and discussion
During a 2 year period starting in October 2013, 37 isolates of P. mirabilis obtained from different patients were referred to our institution. Of these 37 strains, eight were carbapenemaseproducers: two expressed NDM-1, one NDM-5, one VIM-4 and four strains were found to harbour bla OXA-58 . Three of the bla OXA-58 -positive strains were found in urine and one in a rectal swab in hospitalized patients treated in different geographical locations, between 50 and 600 km apart, in Germany. The four strains were found to be not clonally related by PFGE (data not shown).
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In susceptibility tests using microdilution (Table 1 ) MICs of aminopenicillins and ureidopenicillins for all strains were high and indicated resistance of the strains according to EUCAST. The strains were found to be resistant to combinations with b-lactamase inhibitors with the exception of strain 10797, which was found to be susceptible to piperacillin/tazobactam. The four strains were generally susceptible to aztreonam and cephalosporins such as cefuroxime, ceftazidime and cefepime, with the exception of strain 10797, which showed reduced susceptibility to ceftazidime. As expected for P. mirabilis, all strains were found to be nonsusceptible to imipenem. Strain 10797 was susceptible to ertapenem and meropenem, but positive with the EUCAST screening cut-off for carbapenemase detection of .0.125 mg/L for meropenem. The remaining strains were non-susceptible to either ertapenem or meropenem or both. As expected for a class D carbapenemase, no synergy with EDTA or boronic acid was observed. The modified Hodge test was performed with the four strains harbouring bla OXA-58 and also three strains of P. mirabilis that did not carry a carbapenemase. The test was positive for three of the strains carrying bla OXA-58 when performed on MacConkey agar. For the bla OXA-58 -positive strain 13153 and two of three carbapenemase-negative strains, however, the test was not readable due to swarming. When the modified Hodge test was performed on CLED agar, swarming was suppressed in all strains. While the Hodge test was negative for 10797, it was positive for the other three bla OXA-58 -positive strains, but also for one of the carbapenemase-negative control strains. Apart from bla OXA-58 , no b-lactamase genes could be detected in the genome of strain 10818. Conversely, bla CMY-2 was found in strain 10797. Expression of this usually plasmid-encoded Ambler class C b-lactamase may account for the higher MICs of ceftazidime for strain 10797 compared with strain 10818. The results of the Carba NP test were positive in two of the strains and negative or equivocal in the other two. The specific activities of crude lysates of the four P. mirabilis strains were altogether very similar (Table 2 ). For strains 10797 and 17744, which showed the lowest and highest specific activities against imipenem, respectively, specific activities correlated well with detectability by the Carba NP test. For the other two strains, however, this correlation was not convincing. Strain 10818 yielded a higher specific activity than strain 13153 although strain 13153 was clearly positive in the Carba NP test and strain 10818 showed an equivocal result. Hence, the expression level of bla OXA-58 does not seem to be the only factor impacting the detectability of OXA-58 production in P. mirabilis.
Altogether, these results indicate that detection of bla OXA-58 in P. mirabilis can be difficult. One of the four isolates (strain 10797) did not fulfil our criteria for carbapenemase testing and was only detected because the carbapenemase detection protocol was performed accidentally. As PCR diagnostics of carbapenemases in Enterobacteriaceae usually does not include bla OXA-58 it is likely that this gene is easily overlooked in P. mirabilis.
Two strains (10797 and 10818) underwent WGS with the main aim of detecting the genetic structures harbouring bla OXA-58 . The bla OXA-58 sequence was found on contigs of identical length of 6346 bp in each of the draft genomes of both sequenced strains. The flanks of the contig contained identical sequences, suggesting that the contig represented a circular DNA molecule. This hypothesis was confirmed by PCR. The sequence revealed a plasmid (GenBank accession number KU871396) of 6219 bp containing bla OXA-58 (Figure 1) . Upstream of bla OXA-58 , a gene encoding an Lange et al.
ISAba3-like transposase was detected. The bla OXA-58 gene was flanked by inverted repeats (IR) typically associated with ISAba3-like transposase genes. As in previously described bla OXA-58 -carrying plasmids from Acinetobacter (e.g. GenBank accession number CP014479), the left IR was located upstream of bla OXA-58 , while the right IR was located downstream. Remarkably, this excludes the ISAba3-like gene itself from a putative transposition. Further upstream, a rep gene could be detected while downstream of bla OXA-58 the gene aadA14 was located, which codes for a streptomycin 3 0 -adenyltransferase. The rep gene and aadA14 located directly upstream and downstream of the ISAba3-likebla OXA-58 -structure, respectively, were 100% identical to the plasmid pCCK647 described in Pasteurella multocida (GenBank accession number AJ884726). An alignment of the two plasmids is shown in Figure 2 . Further upstream of this rep gene yet another putative repA-like gene could be detected. Its amino acid sequence exhibited 51% homology at 100% query coverage with a repA gene from Stenotrophomonas maltophilia. Downstream of aadA14 a predicted ORF was found that showed low-level homology (35%) at 97% query coverage in its amino acid sequence to a mobilization gene (mobA) located on another plasmid from P. multocida, p1006 (GenBank accession number FJ234438). This indicates this plasmid may be mobilizable although other mobilizable plasmids tend to have three or more genes involved in their mobilization. The size of p10797-OXA-58 excludes the possibility of it being self-transmissible as the size of the tra genes necessary for this ability alone would exceed 6 kb. From the Illuminaderived sequence of p10797-OXA-58, primers were deduced for Sanger sequencing of this plasmid. Sanger sequencing of all four strains positive for bla showed that the plasmids from strains 10797 and 10818 were identical to the NGS-derived sequence of p10797-OXA-58, while the strains 13153 and 17744 were found to have an identical 11 bp deletion at the 5 0 -end of the ISAba3-like transposase gene in their plasmid (GenBank accession number KU871397). In the amino acid sequence, this causes a deletion of amino acids 25-28 and a frameshift, which results in a premature stop codon likely abolishing transposase activity. We were able to transfer p10797-OXA-58 from P. mirabilis 10818 to E. coli C600 Rif R by conjugation. Furthermore, we could transfer p10797-OXA-58 to E. coli DH1 and A. baumannii ATCC 17978 by electroporation. Presence of the plasmid was confirmed by PCR for bla OXA-58 . Susceptibility testing was performed for the transformants and transconjugants in comparison with their respective recipient strains ( Table 3) . MICs of aminopenicillins and ureidopenicillins, their respective inhibitor combinations and temocillin were substantially increased for E. coli strains C600 and DH1 transconjugants and transformants, respectively, compared with their parent strain. No increase in MICs of cephalosporins was detected for A. baumannii ATCC 17978 or E. coli C600 or DH1 carrying p10797-OXA-58 compared with their respective parent strains. The MICs of carbapenems were not increased for the E. coli C600 transconjugant or the DH1 transformant except for a minor increase in the MIC of imipenem for DH1, whereas MICs of carbapenems were all substantially increased for the A. baumannii ATCC 17978 transformant. These results match previous descriptions of OXA-58, yielding lower turnover numbers for carbapenems than for aminopenicillins and no detectable activity against third-generation cephalosporins. 10 The fact that p10797-OXA-58 impacts the MICs of carbapenems for A. baumannii ATCC 17978, but not for E. coli C600 or DH1, may be related to differences in membrane permeability between these strains.
As bla OXA-58 is not intrinsic to A. baumannii, the gene must have entered this species by horizontal gene transfer. In contrast to OXA-23, which has been shown to be derived from an intrinsic b-lactamase in Acinetobacter radioresistens, the origin of OXA-58 remains elusive. 18 Only plasmidic locations have been reported for bla OXA-58 so far. Regarding the immediate genetic environment, bla OXA-58 is mostly embedded in two ISAba3-type ISs located upstream and downstream of bla OXA-58 , respectively. Apart from the ISAba3-like sequence upstream of bla OXA-58 being disrupted by ISAba2-type ISs in some cases, the immediate genetic environment of bla OXA-58 is fairly constant in A. baumannii. [19] [20] [21] Remarkably, the ISAba3 Dissemination of OXA-58 in Proteus mirabilis JAC sequence downstream of bla OXA-58 that is always present in Acinetobacter is absent in the bla OXA-58 -carrying plasmids from P. mirabilis described here. Thus, the genetic environment of bla OXA-58 in p10797-OXA-58 is quite different from what is usually found in Acinetobacter plasmids carrying bla OXA-58 . As association of this particular ISAba3-like sequence with bla OXA-58 seems to be widespread among A. baumannii, it was likely co-transferred to this plasmid together with bla OXA-58 . As all four strains were found to be not clonally related, this indicates a hitherto unknown spread of related bla OXA-58 harbouring plasmids in the species P. mirabilis. We could show that the host range of p10797-OXA-58 includes E. coli and A. baumannii and that conjugational transfer from OXA-58 bearing strains of P. mirabilis to other Enterobacteriaceae is possible. As we could show that the plasmid backbone originally detected in P. multocida could replicate in A. baumannii it is possible that it was transferred to a strain of A. baumannii or to a yet-unknown reservoir species carrying bla OXA-58 . After acquisition of bla OXA-58 by ISAba3-like mediated transposition, the new plasmid was transferred to P. mirabilis from where it was spread among P. mirabilis strains and possibly other Enterobacteriaceae. In conclusion, we were able to demonstrate for the first known time dissemination of a bla OXA-58 -harbouring plasmid in multiple clones of P. mirabilis. Since this gene can be easily overlooked in P. mirabilis further targeted surveillance is necessary. Lange et al.
